Amprius Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMPX research report →
Range $14 – $18
Price Chart
About the company
Amprius Technologies, Inc. is a company primarily focused on the development, production, and supply of advanced lithium-ion battery solutions. Their innovative product line notably includes cutting-edge silicon nanowire anode lithium-ion batteries.
- CEO
- Thomas Michael Stepien
- IPO
- 2022
- Employees
- 97
- HQ
- Fremont, CA, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a deep downtrend, trading well below its 200-day average of 13.287 after a long slide from the 52-week high of 24.225. The setup is still damaged, though the 52-week low at 7.02 shows it is trying to stabilize near the lower end of its range.
Street sentiment is constructive, with a Buy consensus and an average target of 16.67, implying meaningful upside from current levels. Recent updates have mostly been reiterations rather than fresh downgrades, with firms like H.C. Wainwright, UBS, and William Blair keeping positive views intact.
The earnings profile is still uneven: AMPX has beaten 5 of the last 8 quarters, but the most recent report missed by 100% versus estimate. Next-year EPS is still expected to be slightly negative at -0.01, so shareholders should watch for margin progress and a cleaner path to breakeven.
Recent insider activity leans negative on balance, driven by multiple discretionary sales from the CEO, CTO, and a director. The awards and gifts are noise; the signal is the cluster of open-market selling, including 85,000 shares from Donald R. Dixon and several sales by Thomas M. Stepien.
Profitability remains weak, but gross margin is holding at 24.8% and revenue growth is strong at 82.7% year over year. The balance sheet is a support, with $90.5 million in cash against $39.9 million of debt and $50.6 million in net cash, even as operating cash flow stayed negative at -$31.1 million.
AMPX is a niche battery supplier tied to aviation and drone applications, where its silicon-anode platforms give it a differentiated story. The stock still trades like an early-stage growth name, with a valuation profile that remains stretched versus mature industrial peers despite the cash cushion.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $846.13M
- P/E
- -24.04
- Fwd P/E
- 34.16
- PEG
- 1.39
- P/S
- 7.77
- P/B
- 7.90
- EV/EBITDA
- -28.63
- Div Yield
- 0.00%
- Gross Margin
- 24.82%
- Op Margin
- -14.70%
- Net Margin
- -28.43%
- ROE
- -31.14%
- ROIC
- -14.16%
Latest fiscal year · YoY change
- Revenue
- $73.01M+202.1%
- Gross Profit
- $8.26M+145.1%
- Op Income
- $-46,646,000
- Net Income
- $-44,024,000+1.4%
- EPS
- $-0.35+22.2%
- OCF Growth
- +6.7%
- FCF Growth
- +2.8%
- 52W High
- $24.23
- 52W Low
- $5.72
- 50D MA
- $8.75
- 200D MA
- $13.13
- Beta
- 2.38
- RSI (14)
- 33
- Avg Volume
- 5.46M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Amprius delivered record Q3 revenue and kept margins near 27% while raising full-year revenue guidance again on strong drone, aviation and defense demand.· November 11, 2026
- Q3 revenue was a record $39.1 million, up 83% year over year and 15% sequentially.
- Gross margin was 26.9%, near Q2’s 27.3% and well above the 15% margin a year ago.
- Management raised 2026 revenue guidance to $145 million and adjusted EBITDA guidance to at least $2.5 million.
- The company highlighted new product and market wins, including SiCore 500 for long-endurance aviation and first shipments into subsea autonomous vehicles.
- Cash ended at $60.7 million with no debt, while the company continues to fund capacity and supply-chain buildout ahead of 2027 demand.
Revenue was $39.1 million in Q3, up 83% year over year and 15% sequentially. Gross profit was $10.5 million, with gross margin at 26.9%, versus 27.3% in Q2 and 15% a year ago. North America revenue more than doubled to $12.2 million, while Europe held at $23.3 million; 9-month revenue was $101.7 million, up 113%. Net loss was $3.5 million, or $0.02 per share, and adjusted EBITDA was negative $1 million. For 2026, management raised revenue guidance to $145 million, expects gross margin of at least 28%, adjusted EBITDA of at least $2.5 million, net loss of $10 million or less, EPS loss of $0.07 or less per diluted share, and capex below $10 million.
Tim Stepien said demand remains strong across aviation, defense and advanced mobility, and emphasized that Amprius is broadening beyond drones into HAPS, subsea vehicles, robotics, e-mobility and eVTOL. He framed the business as positioned to benefit from rising allied defense spending and a growing need for NDAA-compliant, high-energy-density cells. His tone was confident and expansionary, with repeated emphasis on new products, new customers and a widening technology roadmap.
Ricardo Rodriguez highlighted a record quarter, seventh straight quarter of sequential double-digit top-line growth, and gross margin held at 26.9% despite a tougher mix and higher freight. He explained that roughly 8 points of gross margin were pressured by mix and freight, offset partly by lower Fremont expenses and pricing, and said freight was 11% of revenue in Q3. He also detailed the balance sheet: $60.7 million of cash, no debt, cash down $13.8 million in the quarter, operating cash use of $7.8 million, capex of $5.2 million, and working-capital build including $18.9 million of prepaid expenses, $45.9 million of receivables and $15.9 million of inventory to support Q4 and early 2027 demand.
Analysts focused on the raised 2030 revenue target, defense procurement momentum, technology roadmap execution, competitive dynamics, pricing, and the mix shift toward pouches versus cylindrical cells. Management said the higher long-term revenue view is supported by visible demand and capacity coming online through the South Korean partners and Kaminus, and reiterated that the company is supplying NDA-compliant cells today. On pricing, management said the $350/kWh figure used in the deck is a conservative, long-term floor heavily weighted to cylindrical cells, while recent pricing has actually trended higher, especially for pouches. They also said 2027 should still be drone-dominant, though other applications and U.S. production should become more meaningful over time.
The bull case from this call is that Amprius is seeing real demand translate into orders, not just interest, with record revenue and a third guidance raise in the year. Management also pointed to new product launches, a broader customer base, and increasing U.S. and allied defense demand that could support growth into 2027 and beyond. The company is still operating with no debt and a capital-light model, while adding capacity through partners rather than building a large captive factory.
The main risks discussed were margin volatility from mix and freight, with Q3 freight called out as 11% of revenue and gross margin likely needing a step-up to reach the full-year target. Management also acknowledged that supply-chain ramp, contract-manufacturing execution, and the timing of U.S. and allied defense budgets could affect growth. The long-term opportunity is still dependent on converting announced demand into production capacity and on customers preferring Amprius’s higher-priced, differentiated cells over lower-cost alternatives.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 93.2%
- Shares Outstanding
- 146.64M
- Float Shares
- 136.73M
of shares held by institutions
298 13F filers
Buy/sell ratio 0.13. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 11.46M | ▲ 126.81K |
| Vanguard Group Inc | 7.13M | ▲ 616.04K |
| Vanguard Capital Management LLC | 6.13M | ▲ 570.32K |
| Stephens Investment Management Group LLC | 4.41M | ▲ 3.69M |
| Morgan Stanley | 4.01M | ▼ 1.10M |
| Ubs Group AG | 3.66M | ▼ 411.63K |
| Geode Capital Management, LLC | 3.57M | ▲ 46.28K |
| State Street Corp | 3.32M | ▲ 84.38K |
| Goldman Sachs Group Inc | 1.53M | ▼ 1.01M |
| Hood River Capital Management LLC | 1.48M | ▲ 68.27K |
| Trexquant Investment LP | 1.32M | ▲ 223.67K |
| Citadel Advisors LLC | 1.29M | ▼ 381.75K |
Held by 276 ETFs
Biggest fund positions in AMPX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 26 | Sun Kang | other | 306,709 |
| Nov 13, 26 | Sun Kang | other | 306,709 |
| Aug 21, 26 | Sun Kang | sell | 62,101 |
| Aug 21, 26 | Stefan Constantin Ionel | sell | 29,681 |
| Aug 21, 26 | Stepien Thomas M | sell | 23,529 |
| Aug 24, 26 | Stepien Thomas M | sell | 8,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 346 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMPX coverage
Recent articles, reports, and earnings notes.

Inside the Enovix IPO: Warrant Listing, Risks, and Setup
Enovix Corporation is expected to list on NASDAQ on 2026-11-19 under ENVXW, but the company has not disclosed a price range. This is not a first-time IPO; it is a warrant distribution/listing tied to an already public company. The setup favors investors who want exposure to silicon-anode batteries, but the key watch item is whether commercialization can scale fast enough to justify dilution and ongoing losses.

Our Next Energy SPAC Merger: Domestic Battery Play Meets a Cash Clock
Our Next Energy is a Michigan battery company going public through a merger with WEN Acquisition Corp (Nasdaq: WENN), with the deal expected to close in the first half of 2027. The setup offers exposure to U.S.-made LFP batteries and grid/defense demand, but shareholders should watch redemption risk, dilution, and whether the financing package holds together.

Forge Nano Holdings IPO: What Investors Need to Know
Forge Nano Holdings Inc. Common Stock (NASDAQ: NANO) is expected to list on 2026-10-22, but the company has not disclosed a conventional price range. This is a priced SPAC business combination, not a traditional underwritten IPO. The setup favors investors who want exposure to battery and semiconductor materials, but the deal still carries early-commercialization and financing risk.
Want a deeper read on AMPX?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Amprius Technologies Q3 Earnings Call Highlights
defenseworld.net · Nov 14
Are Business Services Stocks Lagging Amprius Technologies, Inc. (AMPX) This Year?
zacks.com · Nov 13
Amprius Q3 Earnings Call Highlights Margin Push and U.S. Expansion
zacks.com · Nov 12
Amprius Technologies, Inc. $AMPX Shares Newly Purchased by CenterBook Partners LP
defenseworld.net · Nov 12
Amprius Technologies, Inc. (AMPX) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 11
Amprius Technologies Q3 Earnings Call Highlights
marketbeat.com · Nov 11
Amprius Technologies Set to Report Q3 Earnings: What's in the Cards?
zacks.com · Nov 11
Amprius Technologies (AMPX) Reports Q3 Loss, Beats Revenue Estimates
zacks.com · Nov 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice